A Registered Cohort Study of Inflammatory Demyelination Disease

Ning Wang, MD., PhD.

Status: Enrolling

Conditions: Demyelinating Autoimmune Diseases, CNS

Study type: Observational

Funder types: Other

Identifiers

NCT04386018

MRCTA,ECFAH of FMU [2019]216

Details and patient eligibility

About

This study will provide further insights into the natural course of Inflammatory demyelination disease including clinical features，progression, related antibody spectrum and drug treatment effect

Enrollment: 400 estimated patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Outpatient or inpatient
2. Meet the diagnostic criteria of Inflammatory Demyelination Disease.
3. Voluntary participation and informed consent signed by the applicant or his/her family.

Exclusion criteria

1. Severe complications
2. Poor prognosis (<1 year survival)
3. Severe mental disorder and inability to cooperate with the examination.